Blog
EQS-News: Successful completion of 20% capital increase
EQS-News: Successful completion of 20% capital increase
DKSH Sets Strategic Priorities of Growth, Margin Expansion, and Accelerated M&A at Its Capital Markets Day 2024
DKSH Sets Strategic Priorities of Growth, Margin Expansion, and Accelerated M&A at Its Capital Markets Day 2024
Avolta Secures Strategic Partnership with Shenzhen Bao'an International Airport for New Retail and Dining Contract, Marks New Footprint in China
Avolta Secures Strategic Partnership with Shenzhen Bao'an International Airport for New Retail and Dining Contract, Marks New Footprint in China
EQS-News: Formycon receives positive CHMP opinion for FYB203 (aflibercept), a biosimilar candidate to Eylea® under the tradenames AHZANTIVE® and Baiama®
EQS-News: Formycon receives positive CHMP opinion for FYB203 (aflibercept), a biosimilar candidate to Eylea® under the tradenames AHZANTIVE® and Baiama®
EQS-News: DATAGROUP adopts comprehensive package of measures to increase shareholder value
EQS-News: DATAGROUP adopts comprehensive package of measures to increase shareholder value
EQS-Adhoc: DATAGROUP SE: Principle decision on measures at DATAGROUP SE
EQS-Adhoc: DATAGROUP SE: Principle decision on measures at DATAGROUP SE
EQS-Adhoc: Mynaric secures USD 11 million bridge loan and expects to agree on an up to USD 9 million production increase incentive agreement to meet immediate working capital needs
EQS-Adhoc: Mynaric secures USD 11 million bridge loan and expects to agree on an up to USD 9 million production increase incentive agreement to meet immediate working capital needs
EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V. – dissolution becoming effective on 18 November 2024 and suspension of trading on 19 November 2024
EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V. – dissolution becoming effective on 18 November 2024 and suspension of trading on 19 November 2024
EQS-Adhoc: technotrans adjusts its medium-term forecast for the financial year 2025 due to macroeconomic conditions
EQS-Adhoc: technotrans adjusts its medium-term forecast for the financial year 2025 due to macroeconomic conditions
Funding Circle Plc: POS-Transaction in Own Shares
Funding Circle Plc: POS-Transaction in Own Shares
EQS-Adhoc: Aflibercept-Biosimilar FYB203 / AHZANTIVE®/ Baiama® receives positive CHMP Opinion from EMA
EQS-Adhoc: Aflibercept-Biosimilar FYB203 / AHZANTIVE®/ Baiama® receives positive CHMP Opinion from EMA
Director/PDMR Shareholding
Director/PDMR Shareholding
Form 8.3 - The Vanguard Group, Inc.: Tritax EuroBox plc
Form 8.3 - The Vanguard Group, Inc.: Tritax EuroBox plc
Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc
Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc
Form 8.3 - The Vanguard Group, Inc.: SEGRO plc
Form 8.3 - The Vanguard Group, Inc.: SEGRO plc
Form 8.3 - The Vanguard Group, Inc.: PRS REIT plc, The
Form 8.3 - The Vanguard Group, Inc.: PRS REIT plc, The
Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Form 8.3 - The Vanguard Group, Inc.: International Distribution Services plc
Form 8.3 - The Vanguard Group, Inc.: International Distribution Services plc
Form 8.3 - The Vanguard Group, Inc.: Hargreaves Lansdown plc
Form 8.3 - The Vanguard Group, Inc.: Hargreaves Lansdown plc
Form 8.3 - The Vanguard Group, Inc.: Centamin plc
Form 8.3 - The Vanguard Group, Inc.: Centamin plc
Form 8.3 - The Vanguard Group, Inc.: Britvic plc
Form 8.3 - The Vanguard Group, Inc.: Britvic plc
Form 8.3 - The Vanguard Group, Inc.: AngloGold Ashanti plc
Form 8.3 - The Vanguard Group, Inc.: AngloGold Ashanti plc
Invitation: Investors’ Call to Present TX Ventures Fintech Fund
Invitation: Investors’ Call to Present
TX Ventures Fintech Fund
Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc
Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc
Form 8.3 - The Vanguard Group, Inc.: Spirent Communications plc
Form 8.3 - The Vanguard Group, Inc.: Spirent Communications plc


